Euvax B consists of highly purified, non-infectious particles of Hepatitis B surface antigen (HBsAg) adsorbed onto aluminum salts as an adjuvant and preserved with thimerosal. It is a recombinant DNA hepatitis B vaccine derived from HBsAg produced by DNA recombinant technology in yeast cells (Saccharomyces cerevisiae).

Euvax B consists of highly purified, non infectious particles of Hepatitis surface antigen (HBsAg) adsorbed onto aluminium salt as an adjuvant and preserved with thimerosal. It is a recombinant DNA hepatitis B vaccine derived from HBsAg produced by DNA recombinant technology in yeast cells (Saccharomyces cerevisiae).

Jul 25, 2023 · Euvax B est destiné à une injection intramusculaire uniquement. Une dose pédiatrique (nouveau-nés nourissons et enfants jusqu'à l'âge de 15 ans inclus) a un volume de 0,5 ml et contient 10 µg d'AgHBs. Une dose pour adulte (plus de 16 ans) a un volume d'un ml et contient 20 µg d'AgHBs.

Hepatitis B vaccine is a vaccine that prevents hepatitis B. [13] The first dose is recommended within 24 hours of birth with either two or three more doses given after that. [13] This includes those with poor immune function such as from HIV/AIDS and those born premature. [13] It is also recommended that health-care workers be vaccinated. [14]

Dec 31, 2024 · Hepatitis B causes inflammation of the liver, vomiting, and jaundice (yellowing of the skin or eyes). Hepatitis can lead to liver cancer, cirrhosis, or death. The hepatitis B pediatric vaccine is used to help prevent this disease in children and teenagers.

Jul 20, 2023 · Detailed Hepatitis B Adult Vaccine dosage information for adults. Includes dosages for Hepatitis B Prophylaxis; plus renal, liver and dialysis adjustments.

Jun 28, 2022 · The hepatitis B vaccine is recommended for all people up to age 59. It can help prevent this liver infection and reduce the risk of liver disease and cancer.

Discover what Hepatitis B is, its symptoms, and the significance of the Hepatitis B vaccine. Learn how Sanofi's innovative vaccines protect your health.

Hepatitis B vaccine is the most effective strategy for preventing the transmission of hepatitis B virus (HBV) in haemodialysis centers. Nevertheless, lower vaccine responses have been reported in haemodialysis patients as compared with healthy subjects. This study examines the response to Euvax-B in …

Euvax-B was clinically identical (not inferior) to the EngerixB reference vaccine, and either vaccine could be used to achieve the World Health Organization goal of immunizing all infants against hepatitis B.